Daily Stock Analysis, HTGM, HTG Molecular Diagnostics Inc, priceseries

HTG Molecular Diagnostics Inc. Daily Stock Analysis
Stock Information
Open
4.73
Close
4.81
High
4.96
Low
4.66
Previous Close
4.78
Daily Price Gain
0.03
YTD High
7.95
YTD High Date
Feb 16, 2021
YTD Low
4.53
YTD Low Date
Apr 12, 2021
YTD Price Change
-0.18
YTD Gain
-3.61%
52 Week High
13.80
52 Week High Date
Jun 22, 2020
52 Week Low
3.78
52 Week Low Date
Nov 23, 2020
52 Week Price Change
0.04
52 Week Gain
0.84%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 1. 2017
47.55
Mar 2. 2017
50.02
1 Trading Days
5.21%
Link
LONG
Mar 3. 2017
42.15
Mar 7. 2017
51.68
2 Trading Days
22.60%
Link
LONG
Mar 23. 2017
58.95
Apr 4. 2017
91.60
8 Trading Days
55.39%
Link
LONG
Oct 10. 2017
28.35
Oct 31. 2017
35.47
15 Trading Days
25.10%
Link
LONG
Dec 21. 2017
28.50
Jan 17. 2018
46.36
16 Trading Days
62.66%
Link
LONG
Feb 12. 2018
60.75
Feb 27. 2018
70.01
10 Trading Days
15.24%
Link
LONG
Aug 24. 2018
50.85
Sep 12. 2018
62.27
12 Trading Days
22.45%
Link
LONG
Oct 23. 2019
12.00
Nov 7. 2019
13.13
11 Trading Days
9.39%
Link
LONG
May 20. 2020
6.90
May 29. 2020
7.43
6 Trading Days
7.61%
Link
LONG
Jun 2. 2020
8.25
Jun 11. 2020
8.90
7 Trading Days
7.89%
Link
LONG
Jun 17. 2020
10.20
Jun 24. 2020
10.75
5 Trading Days
5.44%
Link
LONG
Sep 17. 2020
5.13
Sep 22. 2020
5.41
3 Trading Days
5.38%
Link
LONG
Nov 25. 2020
4.69
Dec 15. 2020
5.47
13 Trading Days
16.70%
Link
LONG
Jan 4. 2021
4.99
Jan 28. 2021
6.59
17 Trading Days
32.14%
Link
Company Information
Stock Symbol
HTGM
Exchange
NasdaqCM
Company URL
http://www.htgmolecular.com
Company Phone
877-289-2615
CEO
Timothy B. Johnson
Headquarters
Arizona
Business Address
3430 E. GLOBAL LOOP, TUCSON, AZ 85706
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001169987
About

HTG Molecular Diagnostics, Inc. provides molecular technology solutions. It offers products for miRNA, and mRNA measurement for translational research/medicine and molecular diagnostics. Its qNPA molecular technology platform detects changes in gene expression levels; especially from formalin-fixed, paraffin-embedded tissue and other biological sample types. It also offers pharma and diagnostics services. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Description

HTG Molecular Diagnostics, Inc. develops and markets technology platforms that facilitate the routine use of complex molecular profiling. The company's HTG Edge and HTG EdgeSeq platforms consist of instrumentation, consumables, and software analytics that are used in molecular profiling applications, including tumor profiling, biomarker development and prospectively, and molecular diagnostic testing. The company's platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors or sales agents in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.